Biotech Applied Genetic Technologies prices IPO at $12, below the range

By
A A A

Applied Genetic Technologies, a biotech developing gene therapies for orphan eye diseases, raised $50 million by offering 4.2 million shares at $12, below its proposed $13 to $15 range. The Alachua, FL-based company originally filed to sell 3.6 million shares. Applied Genetic Technologies will list on the NASDAQ under the symbol AGTC. Applied Genetic Technologies filed confidentially on November 4, 2013. BMO Capital Markets and Wedbush PacGrow acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: AGTC

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

106,677,560
  • $17.03 ▲ 0.47%
101,357,777
  • $38.65 ▼ 5.57%
61,830,117
  • $89.89 ▼ 4.26%
54,116,071
  • $5.11 ▼ 4.49%
50,121,934
  • $101.06 ▲ 0.10%
49,993,927
  • $3.52 ▼ 1.40%
47,717,687
  • $11.44 ▼ 4.67%
44,793,169
  • $99.05 ▼ 0.93%
As of 9/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com